Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is one of the well-recognized extranodal lymphomas commonly addicted to the B-cell receptor-MYD88 superpathway. We aimed to describe the genomic changes in a patient who progressed through treatment with ibrutinib, a Bruton’s tyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Lucy C., Yannakou, Costas K., Ryland, Georgina, Lade, Stephen, Dickinson, Michael, Campbell, Belinda A., Prince, Henry Miles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032268/
https://www.ncbi.nlm.nih.gov/pubmed/29899297
http://dx.doi.org/10.3390/ijms19061758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032268/
https://www.ncbi.nlm.nih.gov/pubmed/29899297
http://dx.doi.org/10.3390/ijms19061758

Ejemplares similares